Skip to main content

BRADLEY FOSTER & SARGENT INC/CT

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1015086 HARTFORD, CT

Position in REGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$278,722
-$66,648 QoQ
Shares Held
447
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#960
of 1,322 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BRADLEY FOSTER & SARGENT INC/CT holds $1,337,687 across 4 Biotechnology names. REGN ranks #3 (20.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
3 REGN
Regeneron Pharmaceuticals, Inc.
This page
447 $278,722

All Filings in REGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $278,722 447
2026-03-31 $345,370 447
2025-12-31 $348,885 452
2025-09-30 $253,583 451
2025-06-30 $251,475 479
2025-03-31 $303,796 479
2024-12-31 $433,096 608
2024-09-30 $2,005,765 1,908
2024-06-30 $1,958,068 1,863
2024-03-31 $1,793,118 1,863
2023-12-31 $1,701,247 1,937
2023-09-30 $1,613,824 1,961
2023-06-30 $1,409,056 1,961
2023-03-31 $1,611,294 1,961
2022-12-31 $1,414,841 1,961
2022-09-30 $1,350,874 1,961
2022-06-30 $1,159,205 1,961
2022-03-31 $824,834 1,181
2021-12-31 $360,597 571
2021-09-30 $345,557 571
2021-06-30 $284,296 509
2021-03-31 $238,462 504
2020-12-31 $371,028 768
2020-09-30 $401,922 718
2020-03-31 $343,756 704